Hologic (NSDQ:HOLX) said today it launched its Brevera breast biopsy system designed for real-time breast biopsy and verification.
The Marlborough company’s Brevera system features CorLumina imaging technology to streamline the biopsy process and enhance workflow, the company said. The device is intended to increase biopsy accuracy and deliver results at the point of care for more informed decision making.
Hologic touted the Brevera system as the world’s 1st and only such system to combine tissue acquisition, real-time imaging, sample verification and post-biopsy handling in a single device. The system is designed for both 2D and 3D breast biopsies, the company said.
